·Challenges in and Opportunities for Individualizing Diabetes Technology: A Position Statement by the EASD and the ADA Diabetes Technology Working Group
·Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes
·Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association